Pharma

Vendor qualification is a crucial process in the pharmaceutical industry to ensure the quality, safety, and regulatory compliance of raw materials, packaging materials, and intermediates used in Active Pharmaceutical Ingredient (API) manufacturing.Establishing a robust vendor qualification system minimizes risks associated with supply chain disruptions, contamination, and non-compliance with Good Manufacturing Practices (GMP). 𝐖𝐡𝐚𝐭 𝐢𝐬 𝐕𝐞𝐧𝐝𝐨𝐫

Secondary screening : Secondary screening is the systematic, high-precision evaluation of the microorganisms that were initially detected and isolated during primary screening. secondary screening answers the critical industrial question, “Is this microbe efficient, stable, and economically viable for large-scale production?” Core purpose & Purpose The main goal is to separate truly valuable industrial strains from

Failure Mode and Effects Analysis (FMEA) is a proactive risk assessment tool that identifies potential failures in design, manufacturing, or distribution before they occur. In pharmaceuticals, it is vital to protect patient safety, ensure regulatory compliance (such as GMP), and prevent costly recalls or product-quality events. “𝐅𝐚𝐢𝐥𝐮𝐫𝐞 𝐦𝐨𝐝𝐞” means the way, or mode, in which